Current pharmacotherapy options for bulimia nervosa and binge eating disorder

@article{McElroy2012CurrentPO,
  title={Current pharmacotherapy options for bulimia nervosa and binge eating disorder},
  author={Susan L. McElroy and Anna I. Guerdjikova and Nicole Mori and Anne M. O'Melia},
  journal={Expert Opinion on Pharmacotherapy},
  year={2012},
  volume={13},
  pages={2015 - 2026}
}
Introduction: Growing evidence indicates binge eating, defined as the consumption of an abnormally large amount of food accompanied by a sense of loss of control, is an important public health problem. Although psychotherapy may be effective, not all patients respond adequately. Areas covered: This article provides an overview of bulimia nervosa (BN) and binge eating disorder (BED), the two conditions characterized by recurrent binge eating as a core feature, and reviews studies of specific… Expand
Psychopharmacologic Treatment of Eating Disorders: Emerging Findings
TLDR
RCTs of antipsychotics in AN have had mixed results; the only agent with some evidence of efficacy is olanzapine; one study suggests dronabinol may induce weight gain in AN; and preliminary studies suggest lack of efficacy of alprazolam, dehydroepiandrosterone, or physiologic estrogen replacement in AN. Expand
The Pharmacological Options in the Treatment of Eating Disorders
The eating disorders (DCA) are complex systemic diseases with high social impact, which tend to become chronic with significant medical and psychiatric comorbidities. The literature data showed thatExpand
Psychopharmacological Options in the Multidisciplinary and Multidimensional Treatment of Eating Disorders
TLDR
Although EDs are relatively frequent psychiatric disorders in the general population, especially in adolescent and juvenile age groups, evidence based on the scientific evidence of the efficacy of the pharmacological treatment of EDAs remains modest. Expand
ICBT for Eating Disorders
TLDR
Research suggests that treatment adherence is lower in BN patients who are younger and show more dietary restraint and lower BMI at baseline, and evidence for the cost-effectiveness of ICBT programmes is as yet limited. Expand
Binge eating disorder: from clinical research to clinical practice.
TLDR
Growing evidence from the fields of psychopathology and neurobiology converges to support the idea that "overeating" has much in common with other behavioral addictions, and substance abuse treatment agents may show promise for the treatment of BED. Expand
Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans
TLDR
Evidence for the efficacy of monoaminergic treatments for anorexia nervosa is limited, while more support exists for the treatment of BN or BED with Monoaminergic drugs. Expand
Disulfiram for binge eating disorder: an open trail.
TLDR
While disulfiram reduced the frequency of binge eating episodes, side effects were observed in the majority of participants and longer-term placebo-controlled studies are warranted to exclude the contribution of a placebo response. Expand
Managing comorbid obesity and depression through clinical pharmacotherapies
TLDR
The relationship between obesity and mood disorders; the effects of psychotropic medications commonly used in mood disorders on body weight; the psychiatric effects of available anti-obesity medications; and the few treatment studies of medications in obese patients with mood disorders or depressive symptoms are outlined. Expand
Emotional profile of female rats showing binge eating behavior
TLDR
It is found that bingeing rats are much more anxious before the access to margarine, and that this condition is significantly reduced after its consumption, suggesting a compulsive-like trait. Expand
Dietary-induced binge eating increases prefrontal cortex neural activation to restraint stress and increases binge food consumption following chronic guanfacine
TLDR
It is suggested that mPFC is differentially activated in response to an immobilization stress in animals under different dietary conditions and chronic guanfacine, at the dose tested, was ineffective at reducing binge-like eating. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 105 REFERENCES
Treatment of Binge Eating Disorder
  • S. Crow
  • Medicine
  • Current Treatment Options in Psychiatry
  • 2014
TLDR
The most effective approach to treating binge eating disorder is likely psychotherapy combined with medication management as indicated, and for antidepressants, bringing about lasting weight loss appears to be difficult. Expand
Pharmacological management of binge eating disorder: current and emerging treatment options
TLDR
The rationales and data supporting the effectiveness of specific medications or medication classes in treating patients with BED are reviewed, and the role of pharmacotherapy in the BED treatment armamentarium is discussed, suggesting future areas for research. Expand
Treatment of bulimia nervosa with fluvoxamine: A randomized controlled trial
TLDR
The hypothesis that fluvoxamine is well tolerated and effective in reducing binge-eating crises and purging episodes in patients with BN is supported. Expand
Early response to antidepressant treatment in bulimia nervosa
TLDR
Examining the relationship between initial and later response to fluoxetine, the only antidepressant medication approved by the US Food and Drug Administration for the treatment of BN, with the goal of developing guidelines to aid clinicians in deciding when to alter the course of treatment found no reliable relationships between pretreatment characteristics and eventual response to pharmacotherapy. Expand
Treatment of binge-eating disorder with topiramate: a clinical case series.
TLDR
Topiramate was well tolerated, with neurologic side effects the most common, and may be an effective treatment for binge-eating disorder. Expand
Treatment of bulimia nervosa with sertraline: A randomized controlled trial
TLDR
It is confirmed that sertraline is well tolerated and effective in reducing binge-eating crises and purging in patients with BN. Expand
Psychological treatments for bulimia nervosa and binging.
TLDR
The efficacy of CBT and particularly CBT-BN in the treatment of people with bulimia nervosa and also related eating disorder syndromes was supported, and other psychotherapies were also efficacious, particularly interpersonal psychotherapy in the longer-term. Expand
Evidence-based pharmacotherapy of eating disorders.
TLDR
Meta-analyses on efficacy of pharmacotherapy for BN and BED support moderate effect sizes for medication, but generally low recovery rates, and combined treatment with pharmacotherapy and cognitive behaviour therapy has been more effective than either alone. Expand
Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.
TLDR
Overall, each of these neurotransmitter systems provides a promising avenue for new pharmacotherapy development for binge eating, and preclinical and human studies provide a strong rationale for the development of highly-selective drugs that target this neurocircuitry. Expand
Role of Antiepileptic Drugs in the Management of Eating Disorders
TLDR
In conclusion, AEDs have an emerging role in the management of some eating disorders and topiramate appears to have the broadest spectrum of action as an anti-binge eating, anti-purging and weight loss agent. Expand
...
1
2
3
4
5
...